Date of last dose prior to SAE is after date of onset. |
16 (32.7%) |
Date of onset for adverse event is before patient was randomized. |
12 (24.5%) |
End date for concomitant medication is before medication start date. |
4 (8.2%) |
Date of onset for adverse event is after date of resolution. |
4 (8.2%) |
Assessment of Eligibility indicates that FVC is > = 60% of predicted (Q3), yet the Forced Vital Capacity form (Q1–4) contradicts this. |
4 (8.2%) |
Date of data collection is after the date that the eCRF data was posted. |
3 (6.1%) |
Assessment of Eligibility indicates that disease duration is < 5 years (Q5), yet the neuromuscular exam form (date of onset) contradicts this. |
3 (6.1%) |
Start date for condition in medical history is after date of end date. |
2 (4.1%) |
Start date for condition in medical history is after patient was randomized. |
1 (2.0%) |